Current progress with Moraxella catarrhalis antigens as vaccine candidates
about
Predominant Bacteria Detected from the Middle Ear Fluid of Children Experiencing Otitis Media: A Systematic ReviewComprehensive antigen screening identifies Moraxella catarrhalis proteins that induce protection in a mouse pulmonary clearance modelPanel 6: Vaccines.Intranasal immunization of the combined lipooligosaccharide conjugates protects mice from the challenges with three serotypes of Moraxella catarrhalis.Mutant lipooligosaccharide-based conjugate vaccine demonstrates a broad-spectrum effectiveness against Moraxella catarrhalis.Serum antibody response to Moraxella catarrhalis proteins OMP CD, OppA, Msp22, Hag, and PilA2 after nasopharyngeal colonization and acute otitis media in childrenVaccine targets against Moraxella catarrhalis.Molecular aspects of Moraxella catarrhalis pathogenesis.Moraxella catarrhalis: from interactions with the host immune system to vaccine development.Vaccines for children and adults with chronic lung disease: efficacy against acute exacerbations.Role of the zinc uptake ABC transporter of Moraxella catarrhalis in persistence in the respiratory tract.Mucosal immunization with the Moraxella Catarrhalis porin m35 induces enhanced bacterial clearance from the lung: a possible role for opsonophagocytosis.Characterization and evaluation of the Moraxella catarrhalis oligopeptide permease A as a mucosal vaccine antigen.Investigating the potential of conserved inner core oligosaccharide regions of Moraxella catarrhalis lipopolysaccharide as vaccine antigens: accessibility and functional activity of monoclonal antibodies and glycoconjugate derived sera.
P2860
Q26767290-01306079-507F-467B-B74D-42821E30DCD8Q28382833-DCBE5888-3F3C-4F72-ACA7-05D8C2C2E0F6Q33644678-FD27BADC-55EC-4BE3-9A3F-7A591E7BDE4BQ34117703-3C7C4144-438E-4F2A-8F84-360EC10016A3Q35029651-CB43615A-9307-4BFE-8A2C-086B8668EE74Q36173789-4035476B-58B4-4AAE-9C36-8B7FC683CBAAQ36483998-996680B1-DF0B-40E5-9677-D65FA0A70370Q37590025-4D4FB19B-7557-410F-BB40-19BC278076F0Q38041190-137A05D4-A20D-49B3-B67C-A2D005B337ECQ38168915-8A9AC831-7D2B-4A78-BBA1-AE8EBCC80EDAQ39131974-0CFEC8E0-3368-44D1-A9F6-74249FECBCE8Q42143952-CD966059-79F5-42B8-B76D-039534A0D4FDQ42583054-BFEAAC3C-DD8B-475A-B509-7C2684179CA0Q42601451-C1AE3422-28EA-4732-98A2-4FEC58FE7070
P2860
Current progress with Moraxella catarrhalis antigens as vaccine candidates
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Current progress with Moraxella catarrhalis antigens as vaccine candidates
@ast
Current progress with Moraxella catarrhalis antigens as vaccine candidates
@en
Current progress with Moraxella catarrhalis antigens as vaccine candidates
@nl
type
label
Current progress with Moraxella catarrhalis antigens as vaccine candidates
@ast
Current progress with Moraxella catarrhalis antigens as vaccine candidates
@en
Current progress with Moraxella catarrhalis antigens as vaccine candidates
@nl
prefLabel
Current progress with Moraxella catarrhalis antigens as vaccine candidates
@ast
Current progress with Moraxella catarrhalis antigens as vaccine candidates
@en
Current progress with Moraxella catarrhalis antigens as vaccine candidates
@nl
P2093
P2860
P356
P1476
Current progress with Moraxella catarrhalis antigens as vaccine candidates
@en
P2093
Fatme Mawas
Mei Mei Ho
Michael J Corbel
P2860
P356
10.1586/14760584.8.1.77
P407
P577
2009-01-01T00:00:00Z